Playing by the rules

A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutraceutical Business & Technology 2012-03, Vol.8 (2), p.16
Hauptverfasser: Ranson, Paul, Eggers, Melanie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 16
container_title Nutraceutical Business & Technology
container_volume 8
creator Ranson, Paul
Eggers, Melanie
description A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_reports_1024813579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A283869223</galeid><sourcerecordid>A283869223</sourcerecordid><originalsourceid>FETCH-LOGICAL-g929-42d7776e71c54d6258084e0131d62d4280c0161737674f0b6c3c780672ee9113</originalsourceid><addsrcrecordid>eNpNzE1Lw0AQBuA9KFhqb_6AoFcDO_s1m2MpfkFBQe8h2UzSSEzqTnLov3ehHjqH9-WFh7kSK0Bjc68l3ogN87dMZ0E7hStx9zFUp37ssvqUzQfK4jIQ34rrthqYNv-9Fp_PT1-713z__vK22-7zrlBFblSDiI4QgjWNU9ZLb0iChjQao7wMEhygRoemlbULOqCXDhVRAaDX4v789Rin34V4LiMdpzhzCVIZD9pikdDDGXXVQGU_ttMcq_DTcyi3ymvvCqV0Uo8Xql64H4lTcN8dZu6qhfmS_wFixEwu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024813579</pqid></control><display><type>article</type><title>Playing by the rules</title><source>Business Source Complete</source><creator>Ranson, Paul ; Eggers, Melanie</creator><creatorcontrib>Ranson, Paul ; Eggers, Melanie</creatorcontrib><description>A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...</description><identifier>ISSN: 1745-8307</identifier><language>eng</language><publisher>Leatherhead: Via Communications Ltd (formerly Via Media Ltd)</publisher><subject>Compliance ; Dietary minerals ; Dietary supplements ; EU directives ; FDA approval ; Food ; Food industry ; Labeling ; Laws, regulations and rules ; Legislation ; Manufacturers ; Nutrition ; Pharmaceutical industry ; Physiology ; Regulation ; Vitamins</subject><ispartof>Nutraceutical Business &amp; Technology, 2012-03, Vol.8 (2), p.16</ispartof><rights>COPYRIGHT 2012 Via Communications Ltd (formerly Via Media Ltd)</rights><rights>Copyright Via Media UK Ltd. Mar/Apr 2012</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,314,776,780,787</link.rule.ids></links><search><creatorcontrib>Ranson, Paul</creatorcontrib><creatorcontrib>Eggers, Melanie</creatorcontrib><title>Playing by the rules</title><title>Nutraceutical Business &amp; Technology</title><description>A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...</description><subject>Compliance</subject><subject>Dietary minerals</subject><subject>Dietary supplements</subject><subject>EU directives</subject><subject>FDA approval</subject><subject>Food</subject><subject>Food industry</subject><subject>Labeling</subject><subject>Laws, regulations and rules</subject><subject>Legislation</subject><subject>Manufacturers</subject><subject>Nutrition</subject><subject>Pharmaceutical industry</subject><subject>Physiology</subject><subject>Regulation</subject><subject>Vitamins</subject><issn>1745-8307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>N95</sourceid><sourceid>BENPR</sourceid><recordid>eNpNzE1Lw0AQBuA9KFhqb_6AoFcDO_s1m2MpfkFBQe8h2UzSSEzqTnLov3ehHjqH9-WFh7kSK0Bjc68l3ogN87dMZ0E7hStx9zFUp37ssvqUzQfK4jIQ34rrthqYNv-9Fp_PT1-713z__vK22-7zrlBFblSDiI4QgjWNU9ZLb0iChjQao7wMEhygRoemlbULOqCXDhVRAaDX4v789Rin34V4LiMdpzhzCVIZD9pikdDDGXXVQGU_ttMcq_DTcyi3ymvvCqV0Uo8Xql64H4lTcN8dZu6qhfmS_wFixEwu</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Ranson, Paul</creator><creator>Eggers, Melanie</creator><general>Via Communications Ltd (formerly Via Media Ltd)</general><general>Via Media UK Ltd</general><scope>N95</scope><scope>XI7</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>4T-</scope><scope>7WY</scope><scope>7XB</scope><scope>883</scope><scope>88A</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>LK8</scope><scope>M0F</scope><scope>M7P</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYYUZ</scope><scope>Q9U</scope></search><sort><creationdate>20120301</creationdate><title>Playing by the rules</title><author>Ranson, Paul ; Eggers, Melanie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g929-42d7776e71c54d6258084e0131d62d4280c0161737674f0b6c3c780672ee9113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Compliance</topic><topic>Dietary minerals</topic><topic>Dietary supplements</topic><topic>EU directives</topic><topic>FDA approval</topic><topic>Food</topic><topic>Food industry</topic><topic>Labeling</topic><topic>Laws, regulations and rules</topic><topic>Legislation</topic><topic>Manufacturers</topic><topic>Nutrition</topic><topic>Pharmaceutical industry</topic><topic>Physiology</topic><topic>Regulation</topic><topic>Vitamins</topic><toplevel>online_resources</toplevel><creatorcontrib>Ranson, Paul</creatorcontrib><creatorcontrib>Eggers, Melanie</creatorcontrib><collection>Gale Business: Insights</collection><collection>Business Insights: Essentials</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>ABI/INFORM Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade &amp; Industry (Alumni Edition)</collection><collection>Biology Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Trade &amp; Industry</collection><collection>Biological Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><jtitle>Nutraceutical Business &amp; Technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranson, Paul</au><au>Eggers, Melanie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Playing by the rules</atitle><jtitle>Nutraceutical Business &amp; Technology</jtitle><date>2012-03-01</date><risdate>2012</risdate><volume>8</volume><issue>2</issue><spage>16</spage><pages>16-</pages><issn>1745-8307</issn><abstract>A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...</abstract><cop>Leatherhead</cop><pub>Via Communications Ltd (formerly Via Media Ltd)</pub></addata></record>
fulltext fulltext
identifier ISSN: 1745-8307
ispartof Nutraceutical Business & Technology, 2012-03, Vol.8 (2), p.16
issn 1745-8307
language eng
recordid cdi_proquest_reports_1024813579
source Business Source Complete
subjects Compliance
Dietary minerals
Dietary supplements
EU directives
FDA approval
Food
Food industry
Labeling
Laws, regulations and rules
Legislation
Manufacturers
Nutrition
Pharmaceutical industry
Physiology
Regulation
Vitamins
title Playing by the rules
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T05%3A12%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Playing%20by%20the%20rules&rft.jtitle=Nutraceutical%20Business%20&%20Technology&rft.au=Ranson,%20Paul&rft.date=2012-03-01&rft.volume=8&rft.issue=2&rft.spage=16&rft.pages=16-&rft.issn=1745-8307&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA283869223%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1024813579&rft_id=info:pmid/&rft_galeid=A283869223&rfr_iscdi=true